Adma Biologics Inc

-0.03 (-1.80%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)210.22M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$16.29 Million
Adjusted EPS-$0.16
See more estimates
10-Day MA$1.74
50-Day MA$1.77
200-Day MA$2.08
See more pivots

Adma Biologics Inc Stock, NASDAQ:ADMA

465 State Route 17 South, Ramsey, New Jersey 07446-2012
United States of America
Phone: +1.201.478.5552
Number of Employees: 407


ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in the manufacturing, marketing and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment comprises of the immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 2, 2006 and is headquartered in Ramsey, NJ.